| Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas J Zeng, AP See, J Phallen, CM Jackson, Z Belcaid, J Ruzevick, N Durham, ... International Journal of Radiation Oncology* Biology* Physics 86 (2), 343-349, 2013 | 1035 | 2013 |
| Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ... JAMA oncology 6 (5), 650-659, 2020 | 912 | 2020 |
| Combination therapy with anti-PD-1, anti-TIM-3, and focal radiation results in regression of murine gliomas JE Kim, MA Patel, A Mangraviti, ES Kim, D Theodros, E Velarde, A Liu, ... Clinical Cancer Research 23 (1), 124-136, 2017 | 444 | 2017 |
| Epigenetic therapy ties MYC depletion to reversing immune evasion and treating lung cancer MJ Topper, M Vaz, KB Chiappinelli, CEDS Shields, N Niknafs, RWC Yen, ... Cell 171 (6), 1284-1300. e21, 2017 | 440 | 2017 |
| Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition LR Ferguson, H Chen, AR Collins, M Connell, G Damia, S Dasgupta, ... Seminars in cancer biology 35, S5-S24, 2015 | 382 | 2015 |
| Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9 … AU Kishan, RR Cook, JP Ciezki, AE Ross, MM Pomerantz, PL Nguyen, ... Jama 319 (9), 896-905, 2018 | 315 | 2018 |
| Designing a broad-spectrum integrative approach for cancer prevention and treatment KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ... Seminars in cancer biology 35, S276-S304, 2015 | 311 | 2015 |
| Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations JJ Tosoian, MA Gorin, AE Ross, KJ Pienta, PT Tran, EM Schaeffer Nature Reviews Urology 14 (1), 15-25, 2017 | 284 | 2017 |
| MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism EH Shroff, LS Eberlin, VM Dang, AM Gouw, M Gabay, SJ Adam, ... Proceedings of the National Academy of Sciences 112 (21), 6539-6544, 2015 | 272 | 2015 |
| Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model Z Belcaid, JA Phallen, J Zeng, AP See, D Mathios, C Gottschalk, ... PloS one 9 (7), e101764, 2014 | 263 | 2014 |
| EXO1-A multi-tasking eukaryotic nuclease PT Tran, N Erdeniz, LS Symington, RM Liskay DNA repair 3 (12), 1549-1559, 2004 | 261 | 2004 |
| Twist1-induced dissemination preserves epithelial identity and requires E-cadherin ER Shamir, E Pappalardo, DM Jorgens, K Coutinho, WT Tsai, K Aziz, ... Journal of Cell Biology 204 (5), 839-856, 2014 | 240 | 2014 |
| Postmortem molecular screening in unexplained sudden death SS Chugh, O Senashova, A Watts, PT Tran, Z Zhou, Q Gong, JL Titus, ... Journal of the American College of Cardiology 43 (9), 1625-1629, 2004 | 221 | 2004 |
| Lymphocyte-sparing effect of stereotactic body radiation therapy in patients with unresectable pancreatic cancer AT Wild, JM Herman, AS Dholakia, S Moningi, Y Lu, LM Rosati, ... International Journal of Radiation Oncology* Biology* Physics 94 (3), 571-579, 2016 | 212 | 2016 |
| Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results JM Herman, AT Wild, H Wang, PT Tran, KJ Chang, GE Taylor, ... Journal of Clinical Oncology 31 (7), 886-894, 2013 | 211 | 2013 |
| Targeting DDX 3 with a small molecule inhibitor for lung cancer therapy GM Bol, F Vesuna, M Xie, J Zeng, K Aziz, N Gandhi, A Levine, A Irving, ... EMBO molecular medicine 7 (5), 648-669, 2015 | 208 | 2015 |
| The association between chemoradiation-related lymphopenia and clinical outcomes in patients with locally advanced pancreatic adenocarcinoma AT Wild, X Ye, SG Ellsworth, JA Smith, AK Narang, T Garg, J Campian, ... American journal of clinical oncology 38 (3), 259-265, 2015 | 202 | 2015 |
| ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiation FP Vendetti, P Karukonda, DA Clump, T Teo, R Lalonde, K Nugent, ... The Journal of clinical investigation 128 (9), 3926-3940, 2018 | 179 | 2018 |
| PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges SP Rowe, MA Gorin, ME Allaf, KJ Pienta, PT Tran, MG Pomper, AE Ross, ... Prostate cancer and prostatic diseases 19 (3), 223-230, 2016 | 179 | 2016 |
| Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer ZA Yochum, J Cades, H Wang, S Chatterjee, BW Simons, JP O’Brien, ... Oncogene 38 (5), 656-670, 2019 | 171 | 2019 |
Theodore DeWeeseJohns Hopkins UniversityVerified email at jhmi.edu
